Trader J's Inner Circle Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle

NVDA 180.99

+3.9%

Dec 19 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wlcnyc who wrote (11743)	3/24/1999 11:51:00 AM
From: Mkilloran	Read Replies (1) of 56535

Wlcnyc...Yes, VIVUS has 25% of the ED patients in the UK and Sweden with effective sales/marketing by Astra. There are many patients that Viagra does not work on and others that are taking other medications and CAN NOT use Viagra. Astra will be launching sales of MUSE in the 2nd qtr in Europe... look for increased sales next qtr. The news today was in reference to Vivus's next generation of ED product that is better, smaller, does not need to be stored in the fridge, stores at room temp and cost less to make. Look for VVUS stock to be trading in the teens by the 3rd qtr IMO...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next